EMULATE INC

Emulate Inc. specializes in the design, manufacturing, and support of advanced human organ-on-a-chip systems for biomedical research and drug development. The company develops and supplies precision microfluidic platforms—including the ZOE Culture Module and ORB Hub—that replicate human tissue physiology in vitro, enabling high-fidelity modeling of organ-level responses to drugs, toxins, and disease states. Their technical expertise spans microfabrication of rigid and stretchable microfluidic chips, integrated sensor systems, and closed-loop cell culture environments, with a focus on human-relevant biology beyond traditional cell culture or animal models. Emulate Inc. provides end-to-end solutions, from research-grade kit deployment to full-service maintenance and system upgrades, ensuring continuous operational integrity for sensitive in vitro experiments. The contractor maintains a strong, sustained relationship with the Department of Health and Human Services, delivering organ-chip instrumentation and associated maintenance services to support translational research in pharmacology, toxicology, and disease modeling. They also supply specialized platforms to the Department of Veterans Affairs and the Department of Defense for neurodegenerative and physiological stress studies, indicating alignment with federal priorities in personalized medicine and readiness research. Emulate Inc. operates primarily under NAICS 334516 for analytical laboratory instrument manufacturing and 811210 for precision equipment maintenance, reflecting its dual role as both a hardware developer and a service provider for complex biomedical instrumentation. Their market positioning centers on replacing animal testing with human-predictive in vitro systems, serving government-funded biomedical research institutions and clinical translation programs. As a small business structured as a 2L entity based in Boston, Massachusetts, Emulate Inc. leverages its proximity to academic and biotech hubs to support federal R&D missions. The company holds no federal certifications but maintains a focused presence in the life sciences procurement ecosystem through technical excellence and mission-aligned innovation.